瘦蛋白介导的AMPK信号转导途径

瘦蛋白(leptin)介导的腺苷酸激活蛋白激酶(AMP-activated protein kinase,AMPK)信号转导途径在脂肪代谢的调节中起重要作用。瘦蛋白与其受体结合使AMPK信号转导途径激活,最终激活肉碱脂酰转移酶-1,通过促进脂肪酸氧化而参与脂肪代谢的调节。本文主要介绍近年来关于瘦蛋白介导的AMPK信号转导途径的组成、活性调节及其作用机制的最新研究进展。     

瘦蛋白对摄食和能量平衡的调节及其在哺乳动物冬眠中的作用

白色脂肪合成和分泌的瘦蛋白(leptin)作用于下丘脑和外周的代谢产热器官,对摄食和能量平衡起调节作用。摄食和能量平衡的失调,如瘦蛋白抵抗,可以导致肥胖等一系列生理疾病。以体内贮存的脂肪为主要能源物质越冬的冬眠哺乳动物,体重的年周期波动幅度巨大,其摄食和能量平衡调节机制可能不同于一般的非冬眠物种,育肥阶段可能存在瘦蛋白抵抗机制。本文总结了瘦蛋白调节摄食和能量平衡的作用机制以及瘦蛋白对冬眠哺乳动物育肥和冬眠的影响,为进一步研究冬眠哺乳动物的能量平衡提供参考。     

肥胖与瘦蛋白抗性

瘦蛋白(leptin)是由肥胖的基因ob编码的一种多肽类激素,主要生理功能是调节能量代谢、抑制食欲,从而减少体重的增加。但是在人类和啮齿类动物中,均发现肥胖者中血浆瘦蛋白水平升高,所以推测肥胖者体内可能存在明显的瘦蛋白抗性(leptin resistance,LR)。     

基瘦蛋白与其受体介导的信号转导

瘦蛋白是由肥胖基因编码的一种16kDa的活性蛋白质,其三维结构与长链细胞因子家族相似。瘦蛋白受体属I类细胞因子受体家族,包括6种剪接体（OB-Ra、b、c、d、e、f）,广泛分布于中枢及外周组织,其中的功能性受体（OB-Rb）与瘦蛋白结合后可激活Janus激酶/信号转导及转录激活蛋白（JAK-STAT）途径、原活化的蛋白激酶（MAPK）途径、磷脂酰肌醇-3-激酶（PI3K）/磷酸二酯酶3B（PDE3B）/cAMP途径、5＇-AMP活化的蛋白激酶（AMPK）等主要信号途径,在调节能量代谢、神经内分泌和免疫反应等方面发挥多效能作用,并参与肥胖、糖尿病、自身免疫性疾病等的发生发展过程。该文主要结合瘦蛋白及其受体的结构和功能对二者相互作用的模式和信号通路作一综述。     

转基因小鼠乳腺表达人瘦蛋白的研究

利用转基因动物乳腺生产药用蛋白质是近年来研究的热点,在这方面已有不少成功的例子,展现出良好的应用前景[1,2].本研究选择人瘦蛋白基因作为目标基因是因为其表达产物瘦蛋白能对人体内脂肪的蓄积和能量消耗进行有效的反馈调控,美国科学家已将用E.coli表达的人瘦蛋白用于人肥胖症的治疗并取得了良好的治疗效果[3],但尚未见到利用转基因动物乳腺表达这种蛋白质的研究报道.     

母乳中瘦蛋白的生理功能

研究表明,母乳中存在着瘦蛋白。该文介绍母乳中瘦蛋白的含量、瘦蛋白的来源、瘦蛋白在乳中的存在方式及乳中瘦蛋白的生理效应。     

瘦蛋白调控小型哺乳动物产热的分子机制

瘦蛋白(leptin)是由脂肪细胞分泌的、肥胖基因编码的蛋白类激素,其在哺乳动物的体重调节和适应性产热中有重要作用。解偶联蛋白(uncoupling protein,UCP)是动物体内具有解偶联作用的一类蛋白质。UCP-1是分布于褐色脂肪组织(brown adipose tissue,BAT)线粒体内膜上的标志蛋白,其在冷适应和食物资源缺乏等条件下的产热作用已得到印证。UCP-2和UCP-3的生物学功能仍存在争论。瘦蛋白可以通过诱导UCP的表达来促进产热．瘦蛋白诱导UCP表达的机制有二：(1)瘦蛋白通过与下丘脑神经肽Y的拮抗作用诱导UCP的表达;(2)瘦蛋白以交感神经系统为媒介诱导UCP的表达。瘦蛋白诱导UCP-1的表达是调节BAT产热的主要途径。了解瘦蛋白与UCP在产热中的作用对于我们了解动物产热的分子机制和其对低温、营养缺乏等条件下的生理生态适应机制具有重要意义。     

瘦蛋白的研究进展

瘦蛋白的研究进展黄君富房殿春（第三军医大学西南医院分子生物学实验室,重庆６３００３８）关键词瘦蛋白瘦蛋白受体肥胖基因肥胖是机体能量平衡紊乱的结果。当能量摄取超过能量消耗时,多余的能量便贮存于脂肪细胞,最终导致肥胖。对机体能量平衡及脂肪贮存进行更深入的...     

瘦蛋白介导的人食欲与体重调节机制

瘦蛋白(leptin)介导了一个由5个基因的表达与调控组成的食欲调节系统,从而实现了人体重的反馈调节。深入分析类体重调节的,矿子机制对于阐明肥胖发生的生理学机制,以及对于抗肥胖药物的设计和筛选具育重要意义。     

瘦蛋白与皮肤创伤愈合

自1994年瘦蛋白（leptin）被发现以来,其生理作用得到广泛的研究。近年的研究表明,在高等动物的皮肤创伤愈合过程中,胶原与血管的生成、肉芽组织与上皮的再生以及组织的重建等因子,对皮肤的创伤愈合发挥着至关重要的作用,了解瘦蛋白与上述因子之间的相互关系与作用机制,有助于指导治疗,改善预后。     

Circumventing central leptin resistance: lessons from central leptin and POMC gene delivery

We identified that leptin resistance in aged-obese rats has both peripheral and central components. The central resistance is characterized by diminished hypothalamic leptin receptors and impaired leptin signal transduction. We developed a new model of leptin-induced leptin resistance in which application of the central leptin gene delivery produces unabated hypothalamic leptin over-expression. The chronic central elevation of leptin precipitates leptin resistance in young animals devoid of obesity and exacerbates it in mature or aged animals with obesity. Despite leptin resistance, our aged obese, DIO, and leptin-induced leptin resistant rats were fully responsive to central pharmacological melanocortin activation. We propose that the central leptin resistance resides between leptin receptor and melanocortin receptor activation. Our central POMC gene therapy overcame leptin resistance, producing weight and fat loss and improved insulin sensitivity in obese Zucker and aged rats. This success highlights the central melanocortin system as a useful drug target for combating obesity.     

运动改善肥胖症瘦素抵抗及其机制研究进展

大部分肥胖患者体内出现瘦素抵抗,表现为血清瘦素水平异常升高,但机体对瘦素不敏感或无反应,使瘦素抑制食欲、增加能量消耗和降低血糖等功能不能有效发挥.减轻瘦素抵抗被认为是治疗肥胖及肥胖相关疾病的有效途径.运动减轻肥胖、改善糖脂代谢和增强胰岛素敏感性的作用与运动降低瘦素水平、改善瘦素抵抗密切相关.本文在概述瘦素实现生理功能的机制、肥胖症的中枢及外周瘦素抵抗的基础上,主要综述近年来运动减轻肥胖症瘦素抵抗机制的研究进展,包括减轻高瘦素血症、改善中枢和外周瘦素抵抗,以期为运动防治肥胖机制的研究提供新视角.     

Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance

In obesity, anorectic responses to leptin are diminished, giving rise to the concept of "leptin resistance." Increased expression of protein tyrosine phosphatase 1B (PTP1B) has been associated with the attenuation of leptin signaling and development of cellular leptin resistance. Here we report that hypothalamic levels of the tyrosine phosphatase TCPTP are also elevated in obesity to attenuate the leptin response. We show that mice that lack TCPTP in neuronal cells have enhanced leptin sensitivity and are resistant to high-fat-diet-induced weight gain and the development of leptin resistance. Also, intracerebroventricular administration of a TCPTP inhibitor enhances leptin signaling and responses in mice. Moreover, the combined deletion of TCPTP and PTP1B in neuronal cells has additive effects in the prevention of diet-induced obesity. Our results identify TCPTP as a critical negative regulator of hypothalamic leptin signaling and causally link elevated TCPTP to the development of cellular leptin resistance in obesity.     

Hyperleptinemia Is Required for the Development of Leptin Resistance

Leptin regulates body weight by signaling to the brain the availability of energy stored as fat. This negative feedback loop becomes disrupted in most obese individuals, resulting in a state known as leptin resistance. The physiological causes of leptin resistance remain poorly understood. Here we test the hypothesis that hyperleptinemia is required for the development of leptin resistance in diet-induced obese mice. We show that mice whose plasma leptin has been clamped to lean levels develop obesity in response to a high-fat diet, and the magnitude of this obesity is indistinguishable from wild-type controls. Yet these obese animals with constant low levels of plasma leptin remain highly sensitive to exogenous leptin even after long-term exposure to a high fat diet. This shows that dietary fats alone are insufficient to block the response to leptin. The data also suggest that hyperleptinemia itself can contribute to leptin resistance by downregulating cellular response to leptin as has been shown for other hormones.     

Establishment of Leptin-Responsive Cell Lines from Adult Mouse Hypothalamus

Leptin resistance is considered to be the primary cause of obesity. However, the cause of leptin resistance remains incompletely understood, and there is currently no cure for the leptin-resistant state. In order to identify novel drug-target molecules that could overcome leptin resistance, it would be useful to develop in vitro assay systems for evaluating leptin resistance. In this study, we established immortalized adult mouse hypothalamus—derived cell lines, termed adult mouse hypothalamus (AMH) cells, by developing transgenic mice in which SV40 Tag was overexpressed in chromogranin A—positive cells in a tamoxifen-dependent manner. In order to obtain leptin-responsive clones, we selected clones based on the phosphorylation levels of STAT3 induced by leptin. The selected clones were fairly responsive to leptin in terms of STAT3, ERK, and Akt phosphorylation and induction of c-Fos mRNA induction. Pretreatment with leptin, insulin, and palmitate attenuated the c-Fos mRNA response to leptin, suggesting that certain aspects of leptin resistance might be reconstituted in this cellular model. These cell lines are useful tools for understanding the molecular nature of the signal disturbance in the leptin-resistant state and for identifying potential target molecules for drugs that relieve leptin resistance, although they have drawbacks including de-differentiated nature and lack of long-time stability.     

Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice

Conjugated linoleic acid (CLA) induces insulin resistance preceded by rapid depletion of the adipokines leptin and adiponectin, increased inflammation, and hepatic steatosis in mice. To determine the role of leptin in CLA-mediated insulin resistance and hepatic steatosis, recombinant leptin was coadministered with dietary CLA in ob/ob mice to control leptin levels and to, in effect, negate the leptin depletion effect of CLA. In a 2 x 2 factorial design, 6 week old male ob/ob mice were fed either a control diet or a diet supplemented with CLA and received daily intraperitoneal injections of either leptin or vehicle for 4 weeks. In the absence of leptin, CLA significantly depleted adiponectin and induced insulin resistance, but it did not increase hepatic triglyceride concentrations or adipose inflammation, marked by interleukin-6 and tumor necrosis factor-alpha mRNA expression. Insulin resistance, however, was accompanied by increased macrophage infiltration (F4/80 mRNA) in adipose tissue. In the presence of leptin, CLA depleted adiponectin but did not induce insulin resistance or macrophage infiltration. Despite this, CLA induced hepatic steatosis. In summary, CLA worsened insulin resistance without evidence of inflammation or hepatic steatosis in mice after 4 weeks. In the presence of leptin, CLA failed to worsen insulin resistance but induced hepatic steatosis in ob/ob mice.     

Molecular mechanisms associated with leptin resistance: n-3 polyunsaturated fatty acids induce alterations in the tight junction of the brain

High-fat diets cause peripheral leptin resistance, and dietary lipid composition affects sensitivity to leptin. We examined the role of n-3 polyunsaturated fatty acid (PUFA) in peripheral leptin resistance. Dietary PUFAs (0.4% wt/wt) caused insensitivity to peripherally but not intracerebroventricularly administered leptin. n-3 PUFA increased body weight, associated with a significant reduction of leptin concentration in the cerebrospinal fluid. Dietary n-3 PUFA reduced transport of endogenous or exogenously administered leptin into the brain, associated with increased expression of hypothalamic occludin, but caused no change in expression of leptin receptors, proteins associated with leptin signaling or other tight junction proteins. Continuous intracerebroventricular infusion of an antisense morpholino oligonucleotide targeted to occludin mRNA reversed n-3 PUFA-induced insensitivity to peripherally administered leptin. We conclude that n-3 PUFA induces peripheral leptin resistance via an increase in the expression of hypothalamic occludin, reducing paracellular transport of leptin into the brain.     

Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity

Obesity is associated with the development of leptin resistance. However, the effects of leptin resistance on leptin-regulated metabolic processes and the biochemical defects that cause leptin resistance are poorly understood. We have addressed in rats the effect of dietinduced obesity (DIO), a situation of elevated tissue lipid levels, on the well described lipid-lowering effect of leptin in liver, an action that is proposed to be important for the prevention of tissue lipotoxicity and insulin resistance. In addition, we have addressed the role of phosphatidylinositol 3-kinase (PI 3-kinase) in mediating the acute effects of leptin on hepatic lipid levels in lean and DIO animals. A 90-min leptin ( approximately 10 ng/ml) perfusion of isolated livers from lean animals decreased triglyceride levels by 42 +/- 5% (p = 0.006). However, leptin concentrations ranging from approximately 10 to approximately 90 ng/ml had no effect on triglyceride levels in livers from DIO animals. The acute lipid-lowering effect of leptin on livers from lean animals was mediated by a PI 3-kinase-dependent mechanism, because wortmannin and LY294002, the PI 3-kinase inhibitors, blocked the effects of leptin on hepatic triglyceride levels and leptin increased liver PI 3-kinase activity by 183 +/- 6% (p = 0.003) and insulin receptor substrate 1 tyrosine phosphorylation by 185 +/- 30% (p = 0.02) in the absence of PI 3-kinase inhibitors. Contrary to the effects of leptin in lean livers, leptin did not activate PI 3-kinase in livers from DIO rats. These data present evidence for a role for 1). leptin resistance in contributing to the excessive accumulation of tissue lipid in obesity, 2). PI 3-kinase in mediating the acute lipid-lowering effects of leptin in liver, and 3). defective leptin activation of PI 3-kinase as a novel mechanism of leptin resistance.     

Modulation of leptin resistance by protein tyrosine phosphatases

Leptin plays a central role in weight control by suppressing food intake and increasing energy expenditure. The concept of leptin resistance emerged to explain the seemingly paradoxical elevated leptin levels in obesity. Recent discoveries reveal that protein tyrosine phosphatases are key players in leptin resistance by globally suppressing leptin signaling.     

瘦素水平与代谢综合症的关系

随着代谢综合症在世界范围内的广为流行,已经引起人们的高度重视.代谢综合征以肥胖和代谢异常为特征,胰岛素抵抗为主要的病理机制.瘦素主要来源于脂肪组织,是调节体内脂肪储量和维持能量平衡的一种内分泌激素.瘦素缺乏和瘦素抵抗不仅可以直接引起胰岛素抵抗,而且可以通过导致肥胖继而参与胰岛素抵抗的发生,最终引起代谢综合征.瘦素作为一种新的代谢综合征致病因子,参与代谢综合征的发生发展,故调节瘦素水平为临床治疗代谢综合症提供了新的思路和方法.本文综述了瘦素水平与代谢综合症的关系,以及调节瘦素水平治疗代谢综合征的方法.